Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials (2018)
- Authors:
- Autor USP: WELTMAN, EDUARDO - FM
- Unidade: FM
- DOI: 10.1007/s11060-017-2687-2
- Subjects: NEOPLASIAS DO SISTEMA NERVOSO; ONCOLOGIA; GLIOMA; NEUROCIRURGIA; ENSAIO CLÍNICO
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2018
- Source:
- Título do periódico: Journal of neuro-oncology
- ISSN: 0167-594X
- Volume/Número/Paginação/Ano: v. 136, n. 3, p. 585-593, fev. 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MORAES, Fabio Y et al. Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials. Journal of neuro-oncology, v. fe 2018, n. 3, p. 585-593, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-017-2687-2. Acesso em: 28 set. 2024. -
APA
Moraes, F. Y., Mendez, L. C., Taunk, N. K., Raman, S., Suh, J. H., Souhami, L., et al. (2018). Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials. Journal of neuro-oncology, fe 2018( 3), 585-593. doi:10.1007/s11060-017-2687-2 -
NLM
Moraes FY, Mendez LC, Taunk NK, Raman S, Suh JH, Souhami L, Slotman B, Weltman E, Spratt D, Berlin A, Marta GN. Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials [Internet]. Journal of neuro-oncology. 2018 ; fe 2018( 3): 585-593.[citado 2024 set. 28 ] Available from: https://doi.org/10.1007/s11060-017-2687-2 -
Vancouver
Moraes FY, Mendez LC, Taunk NK, Raman S, Suh JH, Souhami L, Slotman B, Weltman E, Spratt D, Berlin A, Marta GN. Funding source, conflict of interest and positive conclusions in neuro-oncology clinical trials [Internet]. Journal of neuro-oncology. 2018 ; fe 2018( 3): 585-593.[citado 2024 set. 28 ] Available from: https://doi.org/10.1007/s11060-017-2687-2 - Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparaties
- Radiocirurgia
- Ototoxicity Evaluation in Medulloblastoma Patients Submitted to Boost Radiotherapy with Intensity Modulated Radiation Therapy (IMRT)
- Radiotherapy and the SUS: A collapse foretold [Editorial]
- Intensity-Modulated and 3D-Conformal Radiotherapy for Whole-Ventricular Irradiation as Compared With Conventional Whole-Brain Irradiation in the Management of Localized Central Nervous System Germ Cell Tumors
- Patterns of care and outcomes in elderly patients with glioblastoma in Sao Paulo, Brazil: A retrospective study
- Fractionated reirradiation (50 to 54 Gy) using intensity modulated radiation therapy (IMRT) for isolated tumor bed recurrence in children with ependymoma
- Outcome of cerebral arteriovenous malformation after linear accelerator radiosurgical retreatment
- Minimizing the uncertainties regarding the effects of delaying radiotherapy for Glioblastoma: A systematic review and meta-analysis
- Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis
Informações sobre o DOI: 10.1007/s11060-017-2687-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
